Stanford Cancer Institute
The Stanford Maternal and Child Health Research Institute partners with the Stanford Cancer Institute (SCI) to fund innovative projects with a focus on maternal and child health research.
The Stanford Cancer Institute an NCI-designated Comprehensive Cancer Center, has particular scientific strengths in cancer cell and stem cell biology, radiation biology, genetics and genomics, immunology and immunotherapy, and molecular imaging. Dating from the first use of the linear accelerator in 1955, Stanford has provided innovative ideas that have greatly advanced the diagnosis and treatment of a wide variety of cancers. Stanford faculty members have pioneered the development of genomic technologies, detection of circulating tumor DNA, and the application of monoclonal antibodies to cancer treatment, among many other major advances. By leveraging the expertise of nearly 500 physicians and researchers, the SCI harnesses the vast intellectual and scientific resources of Stanford University, Stanford Health Care, and Stanford Children’s Health to advance the understanding of cancer and rapidly translate those research discoveries into improved prevention strategies, novel diagnostics, and safer, more effective therapies.